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General : All reactions were carried out in flame-dried glassware under Ar. All the solvents were purified by 
distillation over the drying agents indicated and were transferred under Ar: THF, Et2O (Mg-anthracene), CH2Cl2 
(CaH2), MeCN, Et3N (CaH2), MeOH (Mg), hexane, toluene (Na/K). Flash chromatography: Merck silica gel 60 
(230-400 mesh). IR: Nicolet FT-7199 spectrometer, wavenumbers in cm−1. MS (EI): Finnigan MAT 8200 (70 
eV), ESI-MS: Finnigan MAT 95, accurate mass determinations: Bruker APEX III FT-MS (7 T magnet). NMR: 
Spectra were recorded on a Bruker DPX 300 or AV 400 spectrometer in the solvents indicated; 1H and 13C 
chemical shifts (δ) are given in ppm relative to TMS, 19F chemical shifts in ppm relative to CF3COOH, coupling 
constants (J) in Hz. The solvent signals were used as references and the chemical shifts converted to the TMS 
scale. Melting points: Büchi melting point apparatus B-540 (corrected). Elemental analyses: H. Kolbe, 
Mülheim/Ruhr. Unless stated otherwise, all commercially available compounds (Acros, Fluka, Lancaster, 




[Gold chloro 2-mesityl-5-methylimidazo[1,5-a] pyridin-3-ylidene] ([1·AuCl]): A suspension of [2-mesityl-5-
methylimidazo[1,5-a] pyridinium chloride (100 mg, 0.35 mmol) in CH2Cl2 (3 mL) was treated 
with Ag2O (40.4 mg, 0.17 mmol). After stirring for 4 h in the dark, AuCl(SMe2) (103 mg, 0.35 
mmol) was added, causing the formation of a white precipitate. Stirring was continued for 3 h 
before the AgCl was filtered off over a plug of silica. The filtrate was evaporated to give the title 
complex as a white solid (168 mg, 99 %). 1H NMR (400 MHz, CD2Cl2): δ = 7.42 (d, J = 9.2 Hz, 1H), 7.37 (s, 
1H), 7.07 (s, 2H), 6.96 (t, J = 8.0 Hz, 1H), 6.59 (dd, J = 6.5, 1.0 Hz, 1H), 3.28 (s, 3H), 2.39 (s, 3H), 2.00 ppm (s, 
6H); 13C NMR (75 MHz, CD2Cl2): δ = 162.5, 140.6, 137.1, 137.0, 135.2, 132.6, 129.8, 123.7, 116.9, 116.0, 





; ν~  = 3137, 2921, 1655, 1546, 1490, 1420, 1373, 1321, 1287, 1198, 1154, 
1071, 1034, 860, 793, 780, 714, 686 cm-1; MS (EI): m/z (%): 482 (61) [M]+, 446 (44), 249 (100), 233 (11), 158 
(16), 124 (21), 77 (7), 65 (4), 51 (2), 39 (3); HRMS calcd for C17H18N2AuClNa: 505.07162, found 505.07206. 
[Gold chloro [2](1,4)benzeno[2](5,8)-2-methylimidazo[1,5-a]pyridin-3-ylidenephane] ([2·AuCl]): A 
suspension of [2](1,4)benzeno[2](5,8)-2-methylimidazo[1,5-a]pyridiniumphane iodide (23.3 
mg, 0.06 mmol)1 in CH2Cl2 (1 mL) was treated with Ag2O (6.9 mg, 0.03 mmol). After stirring 
for 4 h at ambient temperature in the dark, AuCl(SMe2) (17.6 mg, 0.06 mmol) was added, 
which caused the formation of a white precipitate. The mixture was stirred for 3 h at ambient 
temperature before the AgCl was filtered off over a plug of silica. The filtrate was evaporated to give the title 
complex as a white solid (29.5 mg, 99 %). 1H NMR (600 MHz, CD2Cl2): δ = 7.05 (s, 1H), 6.65 (dd, J = 7.9, 1.7 
Hz, 1H), 6.63 (dd, J = 7.9, 1.6 Hz, 1H), 6.25 (d, J = 7.0 Hz, 1H), 6.14 (dd, J = 7.9, 1.6 Hz, 1H), 6.08 (d, J = 6.9 
Hz, 1H), 6.04 (dd, J = 7.9, 1.6 Hz, 1H), 4.96 (dd, J = 14.3, 9.9 Hz, 1H), 4.10 (s, 3H), 3.35 (ddd, J = 13.3, 9.9, 
6.9 Hz, 1H), 3.16 (dd, J = 13.3, 10.7 Hz, 1H), 3.10-2.89 ppm (m, 5H); 13C NMR (150 MHz, CD2Cl2): δ = 
161.96, 137.17, 137.16, 136.41, 136.39, 132.02, 131.73, 129.25, 127.45, 127.18, 124.60, 121.96, 113.11, 40.58, 
35.10, 33.82, 32.85, 31.22 ppm; IR (film): ν~  = 3113, 2922, 2851, 1641, 1536, 1499, 1429, 1410, 1378, 1306, 
1262, 1189, 1096, 1047, 1025, 943, 878, 807, 722 cm-1; MS (EI): m/z (%): 494 (22) [M]+, 458 (16), 355 (9), 324 
(3), 262 (7), 221 (1), 157 (3), 130 (4), 104 (100), 78 (6), 51 (2); HRMS calcd for C18H18N2AuClNa: 517.07162, 
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N-((3,6-dimethylpyridin-2-yl)methyl)formamide: A solution of 2-cyano-3,6-dimethylpyridine (470 mg, 3.6 
mmol)2 in acetic acid (60 mL.) was hydrogenated over Pd/C (10 % w/w, 313 mg) in an autoclave 
at 10 bar hydrogen pressure for 3 h. The autoclave was vented and the mixture filtered through a 
pad of Celite which was carefully washed with hot acetic acid (3 x 10 mL). The combined 
filtrates were evaporated and the residue was dissolved in methyl formiate (20 mL). Et3N (0.93 
mL, 7.2 mmol) was added and the mixture heated at 65 °C for 2 h. Evaporation of all volatile materials and 
purification of the residue by flash chromatography (EtOAc) gave the title compound as a yellow solid (531 mg, 
91 %). 1H NMR (400 MHz, CDCl3): δ = 8.38 (bs, 1H), 7.68 (bs, 1H), 7.37 (d, J = 7.6 Hz, 1H), 6.99 (d, J = 7.4 
Hz, 1H), 4.49 (d, J = 4.4 Hz, 2H), 2.51 (s, 3H), 2.24 ppm (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 161.1, 
154.5, 151.4, 138.3, 127.3, 121.7, 40.4, 23.8, 16.9 ppm; IR (film): ν~  = 3287, 5053, 2923, 2887, 1639, 1594, 
1577, 1537, 1465, 1385, 1232, 1117, 1036, 1011, 971, 917, 840, 815, 758, 705, 678 cm-1. MS (EI): m/z (%): 164 
(75) [M]+, 147 (3), 135 (100), 120 (28), 108 (21), 92 (5), 77 (22), 65 (8), 51 (12), 41 (9), 39 (20), 30 (24), 27 
(13); HRMS calcd for C9H12N2O: 164.09496, found 164.09491; elemental analysis calcd(%) for C9H12N2O: C 






5,8-Dimethylimidazo[1,5-a]pyridine: POCl3 (54.6 μl, 0.6 mmol) was added to a solution of N-((3,6-
dimethylpyridin-2-yl)methyl)formamide (500 mg, 3.0 mmol) in toluene (12 mL) and the mixture was 
stirred at 80 ºC for 3 h. After cooling to ambient temperature the solvents were evaporated, the 
residue suspended in CHCl3 (25 mL), the organic phase was washed with NaOH (2 M, 2 x 5 mL) and 
dried over Na2SO4. Evaporation of the solvent and purification of the residue by flash 
chromatography (EtOAc) afforded the title compound as a yellow solid (350 mg, 75 %). 1H NMR (400 MHz, 
CDCl3): δ = 8.02 (s, 1H), 7.47 (s, 1H), 6.47 (d, J = 6.6 Hz, 1H), 6.31 (d, J = 6.6 Hz, 1H), 2.53 (s, 3H), 2.42 ppm 





ν~  = 3137, 2919, 1637, 1563, 1527, 1446, 1394, 1355, 1299, 1262, 1227, 1119, 1064, 1044, 915, 825, 
786, 752, 711 cm-1; MS (EI): m/z (%): 146 (100) [M]+, 131 (6), 119 (16), 104 (9), 91 (12), 77 (8), 65 (7), 58 (3), 
51 (13), 39 (13), 27 (7); HRMS calcd for C9H10N2: 146.08440, found 146.08451; elemental analysis calcd(%) for 
C9H10N2: C 73.94 H 6.89, N 19.16; found C 73.86, H 6.91, N 19.07. 
2,5,8-Trimethylimidazo[1,5-a]pyridin-2-ium iodide: MeI (60 μL, 0.98 mmol) was added to a solution of 5,8-
dimethylimidazo[1,5-a]pyridine (28.5 mg, 0.20 mmol) in THF (2.0 mL) and the mixture was stirred 
at 60 ºC for 18 h. After removal of the solvent, the residue was washed with pentane (3 x 5 mL) and 
dried in vacuo to afford the title compound as a yellow solid (44 mg, 78 %). 1H NMR (400 MHz, 
d6-DMSO): δ = 9.78 (d, J = 1.0 Hz, 1H), 8.38 (d, J = 1.5 Hz, 1H), 7.06 (dd, J = 6.9, 1.1 Hz, 1H), 
6.98 (dd, J = 6.9, 1.0 Hz, 1H), 4.17 (s, 3H), 2.60 (s, 3H), 2.43 ppm (s, 3H); 13C NMR (100 MHz, d6-DMSO): δ = 
131.0, 130.3, 126.1, 125.0, 123.3, 116.0, 114.2, 37.0, 17.1, 16.7 ppm; IR (film): ν~  = 3029, 2985, 1651, 1548, 
1530, 1443, 1400, 1348, 1324, 1305, 1268, 1236, 1186, 1129, 1090, 1061, 1030, 849, 823 cm-1; MS (ESI): m/z 





(2,5,8-Trimethyl-2,3-dihydroimidazo[1,5-a]pyridin-3-yl)gold(I) chloride ([1b·AuCl]): A suspension of 2,5,8-
trimethylimidazo[1,5-a]pyridin-2-ium iodide (31 mg, 108 mmol) in CH2Cl2 (3 mL) was treated 
with Ag2O (124 mg, 54 mmol). After stirring for 3 h at ambient temperature in the dark, 
AuCl(SMe2) (32 mg, 108 mmol) was introduced, which caused the formation of a white precipitate. 
The mixture was stirred for 3 h at ambient temperature before the formed AgCl was filtered off 
over a plug of silica. The filtrate was evaporated to give the title complex as a white solid (21.1 mg, 50 %). 1H 
NMR (400 MHz, CD2Cl2): δ = 7.37 (s, 1H), 6.66 (dd, J = 6.6, 1.1 Hz, 1H), 6.45 (dd, J = 6.7, 0.8 Hz, 1H), 4.20 
(s, 3H), 3.18 (s, 3H), 2.34 ppm (s, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 162.0, 134.1, 134.0, 126.1, 122.2, 




.8 ν~  = 3101, 1651, 1462, 1418, 1365, 1292, 1203, 1099, 1034, 831, 
                                                 
2  M. G. N. Russell, R. W. Carling, J. R. Atack, F. A. Bromidge, S. M. Cook, P. Hunt, C. Isted, M. Lucas, R. 
M. McKernan, A. Mitchinson, K. W. Moore, R. Narquizian, A. J. Macaulay, D. Thomas, S.-A. Thompson, 
K. A. Wafford, J. L. Castro, J. Med. Chem. 2005, 48, 1367-1383. 
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778, 717 cm-1; MS (EI): m/z (%): 392 (70) [M]+, 356 (100), 159 (61), 145 (19), 132 (8), 117 (13), 106 (6), 91 
(15), 77 (9), 65 (7), 51 (7), 39 (6); HRMS calcd for C10H12N2AuClNa: 415.02467, found 415.02499. 
.5
(5-Methyl-2-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-ylidene)gold(I) chloride ([5·AuCl]): NEt3 (65 μl, 
0.47 mmol) was added to a suspension of 5-methyl-2-phenyl-[1,2,4]triazolo[4,3-a]pyridin-2-ium 
tetrafluoroborate (127 mg, 0.43 mmol)3 and AuCl(SMe2) (126 mg, 0.43 mmol) in THF (4 mL) 
and the resulting mixture was stirred for 1.5 h. Evaporation of all volatile materials and 
purification of the residue by flash chromatography (CH2Cl2) provided the title complex as a 
yellow solid (174 mg, 92 %). 1H NMR (400 MHz, CD2Cl2): δ = 8.08-8.03 (m, 2H), 7.67-7.59 (m, 4H), 7.48 (dd, 
J = 9.0, 6.8 Hz, 1H), 6.82 (dpent, J = 6.8, 1.1 Hz, 1H), 3.36 ppm (s, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 
165.7, 149.8, 140.8, 139.1, 132.3, 130.7, 129.9, 125.7, 116.9, 114.1, 23  ppm; IR (film): ν~  = 3056, 2978, 1652, 
1597, 1542, 1536, 1503, 1462, 1423, 1391, 1379, 1351, 1306, 1264, 1231, 1146, 1103, 1079, 1008, 965, 782, 
767, 748, 739, 693, 680, 660 cm-1; MS (EI): m/z (%): 441 (33) [M]+, 405 (72), 209 (100), 182 (11), 168 (22), 154 










uCl]: A solution of KHMDS (89.5 mg, 0.43 mmol) in THF (3 mL) was added dropwise over a 
period of 30 min to a suspension of the parent azolium tetrafluoroborate salt (200 mg, 0.41 
mmol)
Complex [6·
4 and AuCl(SMe2) (126 mg, 0.43 mmol) in THF (4 mL) at -78 °C. After 1 h, the mixture 
was allowed to reach ambient temperature and stirring was continued overnight, causing the 
formation of a grey precipitate. The solvent was evaporated and the residue was suspended in CH2Cl2 (2 mL). 
The mixture was filtered through a short pad of Celite which was carefully washed with CH2Cl2 (5 x 1mL) and 
the combined filtrates were evaporated to give the title complex as a grey solid (150.0 mg, 58 %). 1H NMR (400 
MHz, CD2Cl2): δ = 8.23-8.19 (m, 2H), 7.93-7.85 (m, 8H), 7.79-7.72 (m, 7H), 7.65 (s, 1H), 7.58-7.51 (m, 2H), 
7.49-7.43 ppm (m, 1H); 13C NMR (100 MHz, CD2Cl2): δ = 168.8 (d, J = 31.3 Hz), 145.8 (d, J = 18.8 Hz), 144.3, 
134.8 (d, J = 10.7 Hz), 132, 130.2 (d, J = 14.1 Hz), 129.1, 127.8, 124.4, 12 .0 (d, J = 93.3 Hz), 101.9 ppm (d, 
J = 127.3 Hz). 31P NMR (162 MHz, CD2Cl2): δ = 15.13 ppm; IR (film): ν~  = 3093, 1595, 1492, 1481, 1468, 
1450, 1435, 1349, 1330, 1207, 1162, 1109, 948, 771, 758, 749, 720, 710, 697, 687 cm-1; MS (ESI): m/z (%): 675 




 H], 405 (23), 242 (100), 186 (12), 142 (25); HRMS calcd for 
27H21N2AuClPNa: 659.06886, found 659.06896. 
 
Preparation of the Substrates and Gold-Catalyzed Transformations 
enta-2,3-dienyl)-
y
                                                
C
 
Dimethyl 2-cinnamyl-2-(4-methylpenta-2,3-dienyl)malonate (7)5 and (E)-dimethyl 2-(4-methylp
2-(penta-2,4-dienyl)malonate (15)6 were prepared according to the cited literature procedures. 
lsilyl)prop-2-ynyl)cyclopentanone: nBuLi (1.6 M in hexane, 8 mL, 12.8 mmol) was added to a 
solution of iPr2NH (2 mL, 14.1 mmol) in THF (100 mL) at 0 °C and the resulting mixture was 
stirred at 0 °C for 1 h and then cooled to –40 °C. A solution of 2-cyclopentylidene-1,1-
dimethylhydrazine (1.62 g, 12.8 mmol)
2-(3-(Trimeth
7 in THF (20 mL) was slowly added and the mixture 
stirred at –40 °C for 3 h. A solution of (3-iodo-1-ynyl)trimethylsilane (3.35 g, 14.1 mmol)8 in THF (20 mL) was 
then introduced and the resulting mixture stirred at the same temperature overnight. The reaction was quenched 




3  J. Iglesias-Sigüenza, A. Ros, E. Díez, M. Alcarazo, E. Álvarez, R. Fernández, J. M. Lassaletta, Dalton 
Trans. 2009, 7113-7120. 
4  A. Fürstner, M. Alcarazo, K. Radkowski, C. W. Lehmann, Angew. Chem. 2008, 120, 8426-8430; Angew. 
Chem. Int. Ed. 2008, 47, 8302-8306. 
5  M. R. Luzung, P. Mauleón, F. D. Toste, J. Am. Chem. Soc. 2007, 129, 12402–12403. 
6  P. Mauleón, R. M. Zeldin, A. Z. González, F. D. Toste, J. Am. Chem. Soc. 2009, 131, 6348–6349. 
7  G. Conole, R. J. Mears, H. De Silva, A. Whiting, J. Chem. Soc. Perkin Trans. 1 1995, 1825-1836. 
8  N. F. Langille, T. F. Jamison, Org. Lett. 2006, 8, 3761-3764. 
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ether (150 mL), the organic phase was washed with H2O (2 x 50 mL) and brine (2 x 50 mL), dried over Na2SO4 
and evaporated. The residue was dissolved in THF (50 mL), mixed with aq. oxalic acid solution (4.55 g in 25 
mL H2O, 50.5 mmol) and the resulting heterogeneous mixture was stirred under reflux for 6 h. A standard 
extractive work up followed by distillation of the crude product under reduced pressure (0.6 mbar, 75 °C) 
afforded the title compound as a colorless oil (1.86 g, 75 %). The analytical and spectral properties match those 
1- -
10
previously reported in the literature.9 
yl)-2-(3-(trimethylsilyl)prop-2-ynyl)cyclopentanol: A slurry of anhydrous CeCl3 (801 mg, 
4.24 mmol) in THF (25 mL) was stirred for 1 h at ambient temperature before it was cooled to 
–78 °C. A pre-cooled (–78 °C) solution of isopropenylmagnesium bromide (0.162 M in THF, 
20 mL, 3.24 mmol) was transferred via canula to the cold CeCl3-slurry. After the resulting 
yellow suspension had been stirred for 2 h at –78 °C, a solution of 2-(3-(trimethylsilyl)prop-2-
ynyl)cyclopentanone (210 mg, 1.08 mmol) in THF (10 mL) was slowly added and the mixture allowed to reach 
ambient temperature overnight. Treatment with aq. sat. NH4Cl (30 mL) followed by a standard extractive 
workup and purification of the crude material by flash chromatography (hexanes/tert-butyl methyl ether, 15:1) 
gave the title compound as a colorless oil (221 mg, 87 %). 1H NMR (400 MHz, CDCl3): δ = 5.10 (dd, J = 1.5, 
0.8 Hz, 1H), 4.90 (t, J = 1.5 Hz, 1H), 2.33-2.18 (m, 2H), 2.17-2.07 (m, 1H), 2.02-1.90 (m, 2H), 1.89-1.80 (m, 
1H), 1.78 (d, J = 0.8 Hz, 3H), 1.73-1.57 (m, 4H), 0.13 ppm (s, 9H); 13C NMR ( 0 MHz, CDCl3): δ = 148.3, 
110.8, 106.6, 85.8, 84.6, 44.9, 39.6, 29.6, 21.4, 19.8, 18.8, 0.2 ppm; IR (neat) 
(Prop-1-en-2
ν~  = 3521, 2959, 2873, 2173, 
1248, 1025, 899, 837, 758, 697 cm-1; MS (EI): m/z (%): 236 (4) [M]+, 221 (62), 207 (12), 193 (15), 179 (8), 163 
(7), 145 (18), 131 (30), 107 (10), 91 (10), 79 (9), 73 (100), 69 (10), 59 (10), 41 (14), 29 (3); HRMS calcd for 
C14H24OSi: 236.15965, found 236.15953. 
op-1-en-2-yl)-2-(prop-2-ynyl)cyclopentyloxy)silane (19): K2CO3 (1.0 g, 7.3 mmol) was added 
to a solution of 1-(prop-1-en-2-yl)-2-(3-(trimethylsilyl)prop-2-ynyl)cyclopentanol (216 mg, 0.91 
mmol) in MeOH (7 mL) and the resulting mixture stirred for 2 h. The mixture was then diluted 
with diethyl ether (25 mL), the organic phase was washed with aq. sat. NH4Cl (10 mL) and brine 
(10 mL), dried over Na2SO4 and evaporated. TESOTf (2 mL, 3 mmol) was added dropwise to a solution of the 
residue and 2,6-lutidine (1.9 mL, 8.2 mmol) in CH2Cl2 (2 mL) at 0 °C and the mixture was stirred at 0 °C for 1.5 
h. The reaction was quenched with aq. sat. NaHCO3, the aqueous phase was extracted with CH2Cl2 (2 x 20 mL), 
and the combined organic phases were dried over Na2SO4. Evaporation of the solvent and purification of the 
residue by flash chromatography (hexanes/EtOAc, 10:1) afforded the title compound as a colorless oil (185 mg, 
73 %). 1H NMR (400 MHz, CD2Cl2): δ = 4.99 (d, J = 1.5 Hz, 1H), 4.89-4.87 (m, 1H), 2.28 (ddd, J = 17.1, 3.3, 
3.0 Hz, 1H), 2.16-1.86 (m, 5H), 1.83-1.69 (m, 5H), 1.68-1.54 (m, 2H), 0.94 (t, J = 8.0 Hz, 9H), 0.61 ppm (q, J = 
7.8 Hz, 6H); 13C NMR (100 MHz, CD2Cl2): δ = 148.6, 111.9, 87.0, 85.8, 68.1, 48.6, 37.5, 30.1, 22.3, 20.2, 18.3, 
7.6, 7.1 ppm; IR (neat) 
Triethyl(1-(pr
ν~  = 3313, 2954, 2912, 2876, 2118, 1641, 1457, 1237, 1165, 1121, 1084, 1051, 1007, 
900, 721 cm-1; MS (EI): m/z (%): 278 (12) [M]+, 263 (14), 249 (92), 237 (18), 223 (14), 207 (11), 193 (19), 175 
(6), 145 (20), 131 (7), 115 (32), 103 (100), 87 (48), 75 (71), 59 (31), 47 (15); HRMS calcd for C17H30OSi: 
                                                
278.20660, found 278.20626. 
Representative Procedure for the Gold(I)-Catalyzed Reactions: A solution of (Ph3P)AuCl (2.5 mg, 5 mmol) 
in CH2Cl2 (0.75 mL) was added to a solution of AgSbF6 (1.7 mg, 5 mmol) in CH2Cl2 (0.75 mL) at –5 °C. The 
mixture was stirred for 5 min before a solution of dimethyl 2-cinnamyl-2-(4-methylpenta-2,3-dienyl)malonate 7 
(33 mg, 0.1 mmol)5 in CH2Cl2 (1.5 mL) was introduced.10 The reaction was stirred at –5 °C and monitored by 
GC-MS analysis. Upon full conversion of the substrate, NEt3 (0.05 mL) was added and the mixture was filtered 
through a short pad of silica, which was carefully washed with CH2Cl2. The combined filtrates were evaporated 
and the residue purified by flash chromatography (hexanes/EtOAc, 10:1) to give a mixture of isomers as a 
transparent oil (27.4 mg, 83 %). The ratio of the isomers was determined by 1H NMR to be 10:13:14 = 50:32:18. 
The individual compounds were obtained in pure form by HPLC (Chiralpak IC, n-heptane/i-propanol, 99:1). The 
 
9  Y.-T. Wu, D. Vidovic, J. Magull, A. de Meijere, Eur. J. Org. Chem. 2005, 8, 1625-1636. 
10  For the reactions shown in Table 3 of the paper, the precipitated silver salts were filtered off prior to the 






recorded analytical and spectral data of dimethyl 6-phenyl-7-(propan-2-ylidene)bicyclo[3.2.0]heptane-3,3-
dicarboxylate 105 match those reported in the literature. The analytical and spectral properties of the [3+2] 
adducts are compiled below. All other gold catalyzed reactions were performed analogously, with the resulting 
m
D
products matching the reported data: 17 and 18 (ref. [6]), 22 and 24 (ref [11]). 
ethyl-6-phenyl-3,3a,6,6a-tetrahydropentalene-2,2(1H)-dicarboxylate (13): 1H NMR (400 
MHz, CDCl3): δ = 7.26 (t, J = 7.0 Hz, 2H), 7.17 (tt, J = 7.8, 1.4 Hz, 1H), 7.05 (d, J = 7.0 Hz, 
2H), 3.69 (s, 3H), 3.69 (s, 3H), 3.37-3.29 (m, 2H), 2.54 (tdd, J = 8.3, 7.2, 2.0 Hz, 1H), 2.49 
(ddd, J = 12.5, 8.8, 1.0 Hz, 1H), 2.46 (ddd, J = 12.8, 8.4, 1.0 Hz, 1H), 2.19 (dd, J = 12.8, 6.3 
Hz, 1H), 2.11 (dd, J = 13.2, 4.8 Hz, 1H), 1.64 (s, 3H), 1.37 ppm (s, 3H); 13C NMR (100 
MHz, C Cl3): δ =172.6, 171.9, 146.1, 134.0, 133.6, 128.4, 127.3, 126.0, 63.5, 61.2, 53.7, 52.7, 52.4, 49.0, 41.8, 






ν~  = 3024, 2951, 2875, 1730, 1452, 1434, 1258, 1227, 1200, 1162, 1085, 1058, 
753, 700 cm-1; MS (EI): m/z (%): 328 (26) [M]+, 297 (10), 268 (100), 253 (5), 236 (7), 221 (4), 209 (15), 193 (9), 
m
169 (24), 145 (7), 115 (4), 77 (2), 59 (2); HRMS calcd for C20H24O4Na: 351.15668, found 351.15639.  
ethyl-4-phenyl-3,3a,6,6a-tetrahydropentalene-2,2(1H)-dicarboxylate (14): 1H NMR (400 
MHz, CDCl3): δ = 7.33 (t, J = 7.4 Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H), 7.21 (t, J = 7.4 Hz, 1H), 
3.73-3.80 (m, 1H), 3.72 (s, 3H), 3.62 (s, 3H), 2.50 (ddd, J = 13.6, 8.7, 1.6 Hz, 1H), 2.49 (ddd, 
J = 12.8, 8.2, 1.6 Hz, 1H), 2.44-2.51 (m, 1H), 2.33 (dq, J = 2.0, 8.6 Hz, 1H), 2.06 (dd, J = 
12.8, 9.0 Hz, 1H), 1.78 (dd, J = 13.6, 6.0 Hz, 1H), 1.71 (dd, J = 2.0, 0.9 Hz, 3H), 1.10 ppm 
(d, 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 172.8, 172.1, 138.2, 137.7, 136.9, 128.4, 128.0, 126.3, 61.5, 







ν~  = 2962, 1732, 1435, 1295, 1202, 1086, 
1015, 864, 795, 700 cm-1; MS (EI): m/z (%): 328 (22) [M]+, 313 (2), 297 (9), 268 (100), 253 (6), 236 (7), 221 (4), 
209 (17), 193 (10), 169 (23), 145 (8), 115 (4), 91 (7), 77 (2), 59 (2); HRMS calcd for C20H24O4Na: 351.15668, 
d 351.15703. 
 
X-Ray Crystallographic Study 
XL-97).13 Hydrogen atoms were inserted from geometry consideration using the HFIX option 
σ(I), R1 = 0.098 [I > 2σ(I)], wR2 =  0.209, 96 parameters,  S =  
65, 134 parameters, S = 
                                                
foun
 
Data were recorded using an Bruker-AXS KappaCCD-diffractometer with graphite-monochromated Mo-Kα-
radiation (λ = 0.71073 Å). The crystal was mounted in a stream of cold nitrogen gas and measured at 100 K. The 
structures were solved by direct methods (SHELXS-97)12 and refined by full-matrix least-squares techniques 
against F2 (SHEL
of the program. 
Selected X-ray crystallographic data for complex [2·AuCl]: C18 H18 Au Cl N2, Mr = 494.76  g · mol-1, colorless 
block, crystal size 0.12 x 0.06 x 0.04 mm, orthorhombic, space group Pnma, a = 21.6308(8) Å, b = 9.3463(3) Å, 
c = 7.7429(3) Å, V = 1565.37(10) Å3, Z = 4, Dcalc = 2.099  g · cm3, μ(Mo-Kα) = 9.566 mm-1, semi-empirical 
absorption correction (Tmin.= 0.46/Tmax.= 0.69),  4.35 < θ < 25.03, 15560  measured reflections, 1469 
independent reflections, 1436 reflections with I > 2
1.457, residual electron density +2.1 / -3.3 e · Å-3. 
Selected X-ray crystallographic data for complex [5·AuCl]: C13 H11 Au Cl N3, Mr = 441.66 g · mol-1, colorless 
block, crystal size 0.09 x 0.04 x 0.03 mm, orthorhombic, space group P212121, a = 6.6980(12) Å, b = 
10.0354(17) Å, c = 19.281(3) Å, V = 1296.0(4) Å3, Z = 4, Dcalc = 2.264 g · cm3, μ(Mo-Kα) = 11.541 mm-1, 
Gaussian absorption correction (Tmin.= 0.46/Tmax.= 0.72), 3.66 < θ < 36.39, 43521 measured reflections, 6153 
independent reflections, 6071 reflections with I > 2σ(I), R1 = 0.026 [I > 2σ(I)], wR2 = 0.0
 
11  B. Baskar, H. J. Bae, S. E. An, J. Y. Cheong, Y. H. Rhee, A. Duschek, S. F. Kirsch, Org. Lett. 2008, 10, 
2605-2607. 
12  G. M. Sheldrick, SHELXS-97, Program for the determination of crystal structures, University of Göttingen, 
Germany, 1997. 
13  G. M. Sheldrick, SHELXL-97, Program for least-squares refinement of crystal structures, University of 
Göttingen, Germany, 1997. 
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(I), R1 = 0.034 [I > 2σ(I)], wR2 = 0.092, 
157, 222 parameters, S = 
CCDC, 12 
nion Road, Cambridge CB2 1 EZ, UK (fax: +44-1223-336033 or e-mail: deposit@ccdc.cam.ac.uk
1.064, absolute structure parameter 0.322(8), residual electron density +2.9 / -2.0 e · Å-3. 
Selected X-ray crystallographic data for complex [6·AuCl]: C27 H21 Au Cl N2 P, Mr = 636.84 g · mol-1, 
colorless plate, crystal size 0.16 x 0.07 x 0.04 mm, monoclinic, space group P21n, a = 10.5155(12) Å, b = 
13.9952(16) Å, c = 15.8114(18) Å, β = 102.126(2)°, V = 2275.0(4) Å3, Z = 4, Dcalc = 1.859 g · cm3, μ(Mo-Kα) = 
6.673 mm-1, Gaussian absorption correction (Tmin.= 0.98/Tmax.= 0.98), 1.96 < θ < 35.25, 70140 measured 
reflections, 10183 independent reflections, 8708 reflections with I > 2σ
289 parameters, S = 1.036, residual electron density +4.1 / -2.5 e · Å-3. 
Selected X-ray crystallographic data for compound 13: C20 H24 O4, Mr = 328.39 g · mol-1, colorless plate, 
crystal size 0.22 x 0.08 x 0.06 mm, monoclinic, space group P21, a = 10.9252(5) Å, b = 5.8661(3) Å, c = 
13.8471(6) Å, β = 96.464(2)°, V = 881.80(7) Å3, Z = 2, Dcalc = 1.237 g · cm3, μ(Mo-Kα) = 0.085 mm-1, 
Gaussian absorption correction (Tmin.= 0.98/Tmax.= 1.00), 2.96 < θ < 33.20, 13256 measured reflections, 6558 
independent reflections, 4924 reflections with I > 2σ(I), R1 = 0.063 [I > 2σ(I)], wR2 = 0.
1.030, absolute structure parameter 0.1(11), residual electron density +0.4 / -0.3 e · Å-3. 
Crystallographic data (excluding structure factors) have been deposited with the Cambridge Crystallographic 
Data Centre as supplementary publication number CCDC 774776 ([2·AuCl]), 743804 ([5·AuCl]), 743802 




basis sets to speed up the calculations.18,19,20 All geometries 
ere fully optimized without symmetry constraints. 
 
                                                
Computati l Studies 
 
Density functional theory (DFT) calculations were carried out using Turbomole 5.91.
ona
14 The BP86 functional15,16 
was employed in combination with the def-TZVP basis set.17 The resolution-of-identity (RI roximation was 




14 R. Ahlrichs, M. Bär, M. Häser, H. Horn, C. Kölmel, Chem. Phys. Lett. 1989, 162, 165-169. 
15 A. D. Becke, Phys. Rev. A 1988, 38, 3098-3100. 
16  J. P. Perdew, Phys. Rev. B  1986, 33, 8822-8824. 
17 F. Weigend, R. Ahlrichs, Phys. Chem. Chem. Phys. 2005, 7, 3297-3305.  
18  K. Eichkorn, O. Treutler, H. Öhm, M. Häser, R. Ahlrichs, Chem. Phys. Lett. 1995, 242, 652-660. 
19 K. Eichkorn, F. Weigend, O. Treutler, R. Ahlrichs, Theor. Chem. Acc. 1997, 97, 119-124. 
20 F. Weigend, Phys. Chem. Chem. Phys. 2002, 4, 4285-4291. 
